BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2462882)

  • 1. Interaction of deoxyuridine with fluorouracil and dipyridamole in a human colon cancer cell line.
    Grem JL; Mulcahy RT; Miller EM; Allegra CJ; Fischer PH
    Biochem Pharmacol; 1989 Jan; 38(1):51-9. PubMed ID: 2462882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of fluorouracil metabolism in human colon cancer cells by dipyridamole with a selective increase in fluorodeoxyuridine monophosphate levels.
    Grem JL; Fischer PH
    Cancer Res; 1986 Dec; 46(12 Pt 1):6191-9. PubMed ID: 2946402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
    Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL
    Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical modulation of fluorouracil by dipyridamole: preclinical and clinical experience.
    Grem JL
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):56-65. PubMed ID: 1557658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical modulation of 5-fluorouracil with or without leucovorin by a low dose of brequinar in MGH-U1 cells.
    Chen TL; Erlichman C
    Cancer Chemother Pharmacol; 1992; 30(5):370-6. PubMed ID: 1380407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of dUMP and free FdUMP pools to inhibition of thymidylate synthase by 5-fluorouracil.
    Berger SH; Hakala MT
    Mol Pharmacol; 1984 Mar; 25(2):303-9. PubMed ID: 6608049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of cell death following thymidylate synthase inhibition: 2'-deoxyuridine-5'-triphosphate accumulation, DNA damage, and growth inhibition following exposure to CB3717 and dipyridamole.
    Curtin NJ; Harris AL; Aherne GW
    Cancer Res; 1991 May; 51(9):2346-52. PubMed ID: 2015598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical determinants of 5-fluorouracil response in vivo. The role of deoxyuridylate pool expansion.
    Myers CE; Young RC; Chabner BA
    J Clin Invest; 1975 Nov; 56(5):1231-8. PubMed ID: 1184747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of 5-fluorouracil cytotoxicity in human colon cancer cells by dipyridamole.
    Grem JL; Fischer PH
    Cancer Res; 1985 Jul; 45(7):2967-72. PubMed ID: 4005834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assay of intracellular free and macromolecular-bound metabolites of 5-fluorodeoxyuridine and 5-fluorouracil.
    Washtien WL; Santi DV
    Cancer Res; 1979 Sep; 39(9):3397-404. PubMed ID: 157805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of innate resistance to thymidylate synthase inhibition after 5-fluorouracil.
    Spears CP; Gustavsson BG; Berne M; Frösing R; Bernstein L; Hayes AA
    Cancer Res; 1988 Oct; 48(20):5894-900. PubMed ID: 3167844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement by uridine of the anabolism of 5-fluorouracil in mouse T-lymphoma (S-49) cells.
    Parker WB; Klubes P
    Cancer Res; 1985 Sep; 45(9):4249-56. PubMed ID: 2411399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentially potentiating effects by dipyridamole on cytotoxicity of 5-fluorouracil against three human maxillary cancer cell lines derived from a single tumor.
    Sato S; Kohno K; Hidaka K; Hisatsugu T; Kuwano M; Komiyama S
    Anticancer Drug Des; 1993 Aug; 8(4):289-97. PubMed ID: 8240657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for acyloxymethyl esters of pyrimidine 5'-deoxyribonucleotides as extracellular sources of active 5'-deoxyribonucleotides in cultured cells.
    Freed JJ; Farquhar D; Hampton A
    Biochem Pharmacol; 1989 Oct; 38(19):3193-8. PubMed ID: 2818620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleotide levels and incorporation of 5-fluorouracil and uracil into DNA of cells treated with 5-fluorodeoxyuridine.
    Ingraham HA; Tseng BY; Goulian M
    Mol Pharmacol; 1982 Jan; 21(1):211-6. PubMed ID: 6215571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of adding the topoisomerase I poison 7-ethyl-10-hydroxycamptothecin (SN-38) to 5-fluorouracil and folinic acid in HCT-8 cells: elevated dTTP pools and enhanced cytotoxicity.
    Mullany S; Svingen PA; Kaufmann SH; Erlichman C
    Cancer Chemother Pharmacol; 1998; 42(5):391-9. PubMed ID: 9771954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance of a human ovarian cancer line to 5-fluorouracil associated with decreased levels of 5-fluorouracil in DNA.
    Chu E; Lai GM; Zinn S; Allegra CJ
    Mol Pharmacol; 1990 Sep; 38(3):410-7. PubMed ID: 2402230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3'-Azido-3'-deoxythymidine cytotoxicity and metabolism in the human colon tumor cell line HCT-8.
    Darnowski JW; Goulette FA
    Biochem Pharmacol; 1994 Nov; 48(9):1797-805. PubMed ID: 7980649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous quantification of 5-FU, 5-FUrd, 5-FdUrd, 5-FdUMP, dUMP and TMP in cultured cell models by LC-MS/MS.
    Carli D; Honorat M; Cohen S; Megherbi M; Vignal B; Dumontet C; Payen L; Guitton J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):2937-44. PubMed ID: 19620028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism and RNA incorporation of cyclopentenyl cytosine in human colorectal cancer cells.
    Yee LK; Allegra CJ; Trepel JB; Grem JL
    Biochem Pharmacol; 1992 Apr; 43(7):1587-99. PubMed ID: 1567480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.